Volume 49, Number 9, 2210-2213, DOI: 10.1007/s00125-006-0329-x

Published in partnership with the

Logo

European Association for the Study of Diabetes

Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene

G. Tonini, C. Bizzarri, R. Bonfanti, M. Vanelli, F. Cerutti, E. Faleschini, F. Meschi, F. Prisco, E. Ciacco and M. Cappa, et al.

View Related Documents

Abstract

Fulltext Preview

Image of the first page of the fulltext document